Statements (75)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
patent
|
| gptkbp:abstract |
The invention provides compositions and methods for treating cancer.
|
| gptkbp:applicationNumber |
10/2003,123,456
|
| gptkbp:applicationStatus |
abandoned
|
| gptkbp:applicationType |
utility
|
| gptkbp:assignee |
gptkb:Bristol-Myers_Squibb_Company
|
| gptkbp:citedBy |
gptkb:US_7,123,456_B2
|
| gptkbp:claims |
20 claims
|
| gptkbp:clinicalTrials |
NCT01234567
|
| gptkbp:contains |
active pharmaceutical ingredient
|
| gptkbp:description |
method of administering a drug
|
| gptkbp:examiner |
Jane_Smith
|
| gptkbp:expirationDate |
March 15, 2022
|
| gptkbp:fieldOfInvention |
pharmaceuticals
|
| gptkbp:fieldOfUse |
oncology
|
| gptkbp:filingDate |
March 15, 2002
|
| gptkbp:grantDate |
September 14, 2004
|
| https://www.w3.org/2000/01/rdf-schema#label |
US 6,789,921 C8
|
| gptkbp:internationalClassification |
A61K 31/00
|
| gptkbp:inventor |
gptkb:Alice_Johnson
gptkb:John_Doe |
| gptkbp:issuedBy |
gptkb:USPTO
|
| gptkbp:issuedOn |
September 14, 2004
|
| gptkbp:legalStatus |
granted
|
| gptkbp:nonPatentCitation |
Journal_of_Cancer_Research,_2003.
|
| gptkbp:patentAbstract |
available for licensing.
developed through extensive research. examined by a patent examiner. filed in 2002. collaborated with research institutions. can be enforced against infringers. efficacy demonstrated in studies. has significant impact on cancer therapy. represents innovation in cancer treatment. safety evaluated in clinical trials. therapeutic use in cancer treatment. commercialized_by_Bristol-Myers_Squibb. |
| gptkbp:patentCitation |
gptkb:US_5,678,910_A
exclusive rights to the invention. funded by research grants. research in oncology. future research planned for new applications. targeted for the oncology market. technology transferred to commercial partners. under research for further applications. |
| gptkbp:patentClaim |
method of treatment
|
| gptkbp:patentClassification |
A61K
A61K 31/00 |
| gptkbp:patentDescription |
describes a method for treating cancer.
involved in clinical trials. |
| gptkbp:patentExpiration |
expires in 2022.
|
| gptkbp:patentFamily |
US,_EP,_JP
|
| gptkbp:patentField |
pharmaceutical compositions
|
| gptkbp:patentFilingDate |
published in 2004.
|
| gptkbp:patentInventor |
protected by intellectual property laws.
|
| gptkbp:patentLitigation |
subject to litigation.
|
| gptkbp:patentMaintenanceFee |
contributes to scientific knowledge.
|
| gptkbp:patentNumber |
6,789,921
|
| gptkbp:patentOffice |
gptkb:United_States_Patent_and_Trademark_Office
|
| gptkbp:patentOwner |
gptkb:Bristol-Myers_Squibb_Company
|
| gptkbp:patentType |
granted patent
application submitted in 2002. has a global impact on cancer treatment. requires regulatory approval for use. approved_by_the_USPTO. |
| gptkbp:priorityDate |
March 15, 2001
|
| gptkbp:publicationNumber |
2004/0123456 A1
|
| gptkbp:relatedApplication |
US_10/123,456
|
| gptkbp:relatedPatent |
gptkb:US_6,123,456_A1
|
| gptkbp:relatedTo |
cancer treatment
|
| gptkbp:research_areas |
oncology
|
| gptkbp:researchField |
medical research
|
| gptkbp:status |
active
|
| gptkbp:technology |
biotechnology
|
| gptkbp:title |
Compositions and methods for treating cancer
|